Cargando…
Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal
Background Direct-acting antivirals (DAA) have revolutionized the treatment of chronic hepatitis C patients. However, the real-life data regarding its use in a human immunodeficiency virus (HIV) co-infection from a developing country is lacking. We aimed to see the efficacy of DAA in hepatitis C vir...
Autores principales: | KC, Sudhamshu, Karki, Niyanta, Sharma, Dilip, Khadka, Sandip, Tiwari, Pratap S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311391/ https://www.ncbi.nlm.nih.gov/pubmed/34336433 http://dx.doi.org/10.7759/cureus.15932 |
Ejemplares similares
-
Prevalence of Portal Hypertensive Gastropathy in Chronic Liver Disease and Correlation with the Severity of Liver disease
por: Tiwari, Pratap S, et al.
Publicado: (2019) -
Prevalence of Acute Kidney Injury in Patients with Liver Cirrhosis
por: Thapa, Pukar, et al.
Publicado: (2020) -
Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020) -
Metabolic Syndrome in Patients with Non-alcoholic Fatty Liver Disease: A Community Based Cross-sectional study
por: Paudel, Mukesh S, et al.
Publicado: (2019) -
Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
por: Shrestha, Rupesh, et al.
Publicado: (2021)